Form 8-K - Current report:
SEC Accession No. 0001437749-14-007644
Filing Date
2014-05-01
Accepted
2014-05-01 09:06:59
Documents
3
Period of Report
2014-04-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bota20140501_8k.htm 8-K 21442
2 EXHIBIT 99.1 ex99-1.htm EX-99 15490
3 logo.jpg GRAPHIC 7042
  Complete submission text file 0001437749-14-007644.txt   48178
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 14802204
SIC: 2836 Biological Products, (No Diagnostic Substances)